Top-News

West Pharmaceutical Services Aktie News

Aktie
WKN:  864330 ISIN:  US9553061055 US-Symbol:  WST Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
243,70 €
+2,80 €
+1,16%
13:13:06 Uhr
Depot/Watchlist
Marktkapitalisierung *
16,29 Mrd. €
Streubesitz
1,12%
KGV
48,96
Dividende
0,22 $
Dividendenrendite
0,08%
neu: Nachhaltigkeits-Score
32 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,37: MM18JW
Werbung

West Pharmaceutical Services News

27.10.25 - PR Newswire
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-​level solution for drug delivery PR Newswire
24.10.25 - PR Newswire
West to Participate in Upcoming Investor Conferences
West to Participate in Upcoming Investor Conferences PR Newswire
23.10.25 - PR Newswire
West Reports Third-Quarter 2025 Results
West Reports Third-​Quarter 2025 Results PR Newswire
18.10.25 - wallstreetONLINE Redaktion
Community Rückblick: "Ich hab das Bedürfnis dort morgen hinzufahren und komplett auszurasten"
Die Gerresheimer Aktie crashte in der letzten Woche erneut, nachdem eine Absenkung der Jahres­prognose bekanntgeben wurde. Die Investierten innerhalb der wO-​Community ...
18.10.25 - wallstreetONLINE Redaktion
Community Rückblick: "Ich hab das Bedürfnis dort morgen hinzufahren und komplett auszurasten"
Foto: Revierfoto - Revierfoto Die Gerresheimer Aktie crashte in der letzten Woche erneut, nachdem eine Absenkung der Jahres­prognose bekanntgeben wurde. Die Investierten ...
09.10.25 - PR Newswire
West to Host Third-Quarter 2025 Conference Call
West to Host Third-​Quarter 2025 Conference Call PR Newswire
21.08.25 - PR Newswire
West to Participate in Upcoming Investor Conferences in September 2025
West to Participate in Upcoming Investor Conferences in September 2025 PR Newswire
24.07.25 - PR Newswire
West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance
West Announces Second-​Quarter 2025 Results and Fourth-​Quarter 2025 Dividend, Updates Full-Year 2025 Guidance PR Newswire
21.07.25 - PR Newswire
West Welcomes Robert McMahon as Incoming Chief Financial Officer
West Welcomes Robert McMahon as Incoming Chief Financial Officer PR Newswire
08.07.25 - PR Newswire
West to Host Second-Quarter 2025 Conference Call
West to Host Second-​Quarter 2025 Conference Call PR Newswire
07.07.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming ...
07.07.25 - PR Newswire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
07.07.25 - PR Newswire
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact The Gross Law Firm
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire
07.07.25 - PR Newswire
WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST
WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST PR Newswire
03.07.25 - PR Newswire
WST LAWSUIT ALERT: The Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
WST LAWSUIT ALERT: The Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
03.07.25 - PR Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services PR Newswire
02.07.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming ...
01.07.25 - PR Newswire
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
01.07.25 - PR Newswire
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
30.06.25 - PR Newswire
WST Deadline: WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
WST Deadline: WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +0,36%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »